Bob Sharma
Contributor since: 2014
Company: Vasuda healthcare analytics
Latest Articles
My Favorite Investment For The Coming Biotech Bull Market (Bhavneesh Sharma)
Ovid Therapeutics: Beaten-Down IPO With Upcoming 2018 Catalysts
Adverum Biotechnologies: Gene Therapy Company And Our New Buy
U.S. Biotech/Pharma Sector Daily Observations Letter: March 27, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: March 26, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: March 22, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: March 21, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: March 20, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: March 19, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: March 15, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: March 14, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: March 13, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: March 12, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: March 7, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: March 6, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: March 5, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: March 1, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: February 27, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: February 26, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: February 22, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: February 21, 2018
ARMO BioSciences: Analysis And Valuation Of Recent Immune-Oncology IPO
U.S. Biotech/Pharma Sector Daily Observations Letter: February 20, 2018
Financial Exchange Stock Talk: Bob Sharma On ARMO BioSciences
U.S. Biotech/Pharma Sector Daily Observations Letter: February 15, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: February 14, 2018, Featuring DBV Technologies
U.S. Biotech/Pharma Sector Daily Observations Letter: February 13, 2018 (Featuring Tetraphase Pharmaceuticals)
Solid Biosciences: Initiating Coverage With A Sell Rating And First Price Target Of $18
U.S. Biotech/Pharma Sector Daily Observations Letter: February 12, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: Feb. 7, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: February 6, 2018
U.S. Biotech/Pharma Sector Daily Observations Letter: February 5, 2018